These somehow controversial findings indicate that further experimental research is needed to better understand the role of CD36 in regulating hepatic lipid homeostasis and its impact in the progression of hepatosteatosis to NASH. Here, CD36 is linked to metabolic dysfunction-associated steatohepatitis.